Principal Investigator, DCLab IICB
Dipyaman Ganguly
Biodata
Senior Scientist & Swarnajayanti Fellow, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Assistant professor, Academy of Scientific & Innovative Research, Govt. of India.
Email: dipyaman@iicb.res.in
Website: http://iicb.res.in/dipyaman-ganguly/
Research Interests: Innate Immune Regulation, Dendritic Cell Biology, Autoreactive Inflammation, Cancer Immunosurveillance, History & Philosophy of Science
Academic:
PhD in Immunology and Biomedical Science, 2010, UT MD Anderson Cancer Center, Houston, USA.
PhD in Biotechnology, 2008, Indian Institute of Chemical Biology, Kolkata, India.
MBBS, 2001, Medical College & Hospitals, Calcutta, India.
Positions held:
01/2014-till date: Senior Scientist, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
04/2014-till date: Assistant Professor, Academy of Scientific & Innovative Research, India.
01/2013-till date: Ramanujan Fellow and Principal Investigator, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
07/2010-12/2012: S.L.E.Foundation Postdoctoral Fellow, Columbia University, New York City, USA.
08/2006-05/2010: Graduate Research Assistant, UT MD Anderson Cancer Center, Houston, USA.
11/2003-08/2006: Senior Research Fellow, Indian Institute of Chemical Biology, Kolkata, India.
03/2003-10/2003: Clinical Associate, Institute of Genomics and Integrative Biology, Delhi, India.
Honors and Awards:
2011- Ramanujan Fellowship, Dept. of Science & Technology, Govt. of India.
2011- Lupus Foundation Postdoctoral Fellowship from the S.L.E. Foundation, New York.
2009- Keystone Symposium Scholarship.
2007- Vivian L. Smith Outstanding Young Immunologist Award from the Center for Cancer Immunology Research, UT MD Anderson Cancer Center, Houston, Texas, USA.
2005- Best Paper Award at the 32nd Indian Immunology Society Conference, Chandigarh, India.
2004- Best poster award at the 31st Indian Immunology Society Conference, Chennai, India.
Total publications: 19
Total citations: 2006
Average citations: 105.57
Average Impact Factor: ~8
H index: 14
Patents:
Inhibitors of phosphatidylinositol-3-kinase and nitric oxide.
US Patent App. 13/144,263.
EP Patent 2,385,934
Invited talks:
October, 2006: Center for Immunology and Inflammatory Disease, Harvard University, Cambridge, USA.
October, 2009: Center for Neurologic Disease, Harvard Institutes of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
October, 2009: Department of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, USA
October, 2009: Department of Molecular & Cell Biology, University of California, Berkeley, USA
February, 2010: Icahn Medical Institute, Mount Sinai Hospital, New York, USA.
February, 2010: Department of Microbiology and Immunology, College of Physicians and Surgeons, Columbia University, New York, USA.
February, 2011: Institute of Genomics and Integrative Biology, Delhi, India.
March, 2011: Indian Institute of Chemical Biology, Kolkata, India.
September, 2014: College of Medicine & JNM Hospital, Kalyani, India.